These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
395 related articles for article (PubMed ID: 25164154)
1. Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipation. Camilleri M; Drossman DA; Becker G; Webster LR; Davies AN; Mawe GM Neurogastroenterol Motil; 2014 Oct; 26(10):1386-95. PubMed ID: 25164154 [TBL] [Abstract][Full Text] [Related]
2. Definition, diagnosis and treatment strategies for opioid-induced bowel dysfunction-Recommendations of the Nordic Working Group. Drewes AM; Munkholm P; Simrén M; Breivik H; Kongsgaard UE; Hatlebakk JG; Agreus L; Friedrichsen M; Christrup LL Scand J Pain; 2016 Apr; 11():111-122. PubMed ID: 28850449 [TBL] [Abstract][Full Text] [Related]
3. Clinical Overview and Considerations for the Management of Opioid-induced Constipation in Patients With Chronic Noncancer Pain. Viscusi ER Clin J Pain; 2019 Feb; 35(2):174-188. PubMed ID: 30289777 [TBL] [Abstract][Full Text] [Related]
4. Treatment of opioid-induced constipation: focus on the peripheral μ-opioid receptor antagonist methylnaltrexone. Rauck RL Drugs; 2013 Aug; 73(12):1297-306. PubMed ID: 23881667 [TBL] [Abstract][Full Text] [Related]
5. Improving the recognition and diagnosis of opioid-induced constipation in clinical practice. Gupta A J Fam Pract; 2015 Oct; 64(10 Suppl 1):. PubMed ID: 26561554 [TBL] [Abstract][Full Text] [Related]
7. Peripherally Acting μ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications. Streicher JM; Bilsky EJ J Pharm Pract; 2018 Dec; 31(6):658-669. PubMed ID: 28946783 [TBL] [Abstract][Full Text] [Related]
8. Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with gastrointestinal cancer. Harada T; Imai H; Fumita S; Noriyuki T; Gamoh M; Okamoto M; Akashi Y; Kizawa Y; Tokoro A Int J Clin Oncol; 2021 Jan; 26(1):104-110. PubMed ID: 33068220 [TBL] [Abstract][Full Text] [Related]
9. Patients' Self-Assessment of the Symptoms and Impact of Opioid-Induced Constipation: Results From a Prospective Observational Cohort Study of Japanese Patients With Cancer. Fumita S; Imai H; Harada T; Noriyuki T; Gamoh M; Akashi Y; Sato H; Kizawa Y; Tokoro A J Pain Symptom Manage; 2020 May; 59(5):1043-1051.e2. PubMed ID: 31805362 [TBL] [Abstract][Full Text] [Related]
10. Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain. Webster L; Jansen JP; Peppin J; Lasko B; Irving G; Morlion B; Snidow J; Pierce A; Mortensen E; Kleoudis C; Carter E Pain; 2008 Jul; 137(2):428-440. PubMed ID: 18164818 [TBL] [Abstract][Full Text] [Related]
11. Opioid-Induced Constipation Survey in Patients with Chronic Noncancer Pain. Rauck RL; Hong KJ; North J Pain Pract; 2017 Mar; 17(3):329-335. PubMed ID: 26990277 [TBL] [Abstract][Full Text] [Related]
12. The role of opioid receptor antagonists in the treatment of opioid-induced constipation: a review. Leppert W Adv Ther; 2010 Oct; 27(10):714-30. PubMed ID: 20799006 [TBL] [Abstract][Full Text] [Related]
13. Review document of the Spanish Association of Neurogastroenterology and Motility on the management of opioid-induced constipation. Serra J; Alcedo J; Barber C; Ciriza de Los Ríos C Rev Esp Enferm Dig; 2024 Oct; 116(10):546-553. PubMed ID: 38305669 [TBL] [Abstract][Full Text] [Related]
14. Definitions and outcome measures of clinical trials regarding opioid-induced constipation: a systematic review. Gaertner J; Siemens W; Camilleri M; Davies A; Drossman DA; Webster LR; Becker G J Clin Gastroenterol; 2015 Jan; 49(1):9-16. PubMed ID: 25356996 [TBL] [Abstract][Full Text] [Related]
15. Translating Clinical Findings into the Patient's Perspective: Post-hoc Pooled Analysis of Bowel Movement Changes as a Predictor of Improvement in Patients' Opioid-induced Constipation Symptoms and Outcomes. Coyne KS; Poon JL; Thompson C; Hu Y; Datto CJ; Sostek M Clin Ther; 2017 Jan; 39(1):75-88. PubMed ID: 27938897 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of Treatments for Opioid-Induced Constipation: Systematic Review and Meta-analysis. Nee J; Zakari M; Sugarman MA; Whelan J; Hirsch W; Sultan S; Ballou S; Iturrino J; Lembo A Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1569-1584.e2. PubMed ID: 29374616 [TBL] [Abstract][Full Text] [Related]
17. Current concepts in the management of opioid-induced constipation. Walters JB; Montagnini M J Opioid Manag; 2010; 6(6):435-44. PubMed ID: 21269005 [TBL] [Abstract][Full Text] [Related]
18. Narcotic bowel syndrome and opioid-induced constipation. Szigethy E; Schwartz M; Drossman D Curr Gastroenterol Rep; 2014 Oct; 16(10):410. PubMed ID: 25183577 [TBL] [Abstract][Full Text] [Related]
19. Non-analgesic effects of opioids: management of opioid-induced constipation by peripheral opioid receptor antagonists: prevention or withdrawal? Holzer P Curr Pharm Des; 2012; 18(37):6010-20. PubMed ID: 22747544 [TBL] [Abstract][Full Text] [Related]
20. Peripherally acting μ-opioid antagonist for the treatment of opioid-induced constipation: Systematic review and meta-analysis. Nishie K; Yamamoto S; Yamaga T; Horigome N; Hanaoka M J Gastroenterol Hepatol; 2019 May; 34(5):818-829. PubMed ID: 30597600 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]